COVID-19: Poor outcomes in patients with zinc deficiency

• Published in: International journal of infectious diseases Vol. 100; pp. 343 - 349
• Main Authors: Jothimani, Dinesh, Kailasam, Ezhilarasan, Danielraj, Silas, Nallathambi, Balaji, Ramachandran, Hemalatha, Sekar, Padmini, Manoharan, Shruthi, Ramani, Vidyalakshmi, Narasimhan, Gomathy, Kaliamoorthy, Ilankumaran, Rela, Mohamed
• Format: Journal Article
• Language: English
• Published: Canada Elsevier Ltd 01.11.2020; Published by Elsevier Ltd on behalf of International Society for Infectious Diseases; Elsevier
• Subjects: Adolescent; Adult; Aged; Antiviral Agents - therapeutic use; COVID-19; COVID-19 - blood; COVID-19 - complications; COVID-19 - therapy; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Pandemics; Prospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult; Zinc; Zinc - blood; Zinc - deficiency; COVID-19; SARS-CoV-2; Zinc

•Patients with coronavirus disease 2019 (COVID-19) had significantly low zinc levels in comparison to healthy controls.•Zinc deficient patients developed more complications (70.4% vs 30.0%, p = 0.009).•Zinc deficient COVID-19 patients had a prolonged hospital stay (7.9 vs 5.7 days, p = 0.048).•In vi...